-
-
-
-
-
-
-
Revolution Medicines, Inc. (RVMD) Misses Q1 EPS by 46c, provides guidance
-
-
-
-
-
-
-
Revolution Medicines, Inc. (RVMD) Misses Q3 EPS by 20c
-
-
-
-
-
-
-
Revolution Medicines Reports First Quarter 2025 Financial Results and Update on Corporate Progress
-
-
-
-
-
-
-
Revolution Medicines, Inc. (RVMD) Misses Q3 EPS by 5c
-
-
-
-
-
-
-
Revolution (RVMD) PT Raised to $55 at JPMorgan
-
-
-
-
-
-
-
Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2023 After Market Close on February 26, 2024
-
-
-
-
-
-
-
Revolution Medicines, Inc. (RVMD) Tops Q1 EPS by 10c
-
1,219,727 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

